Serum metabolomic profile of glioma risk in the comets consortium
Ended Awarded Last action
- Contract number
- 75N91019F00131
- Awardee
-
Metabolon, Inc. UEI SBY5A7EK9PU3
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $403,620
Award facts
- Opportunity
-
- N02CP7100272 Solicitation number
- Metabolomic Profiling for Molecular Epidemiology Studies Award Notice · Posted Oct 31, 2016
- Contract value 100% obligated
- $403,620.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Time and Materials
- Place of performance
- Morrisville, NC, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $403,620 |
About this award
This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Metabolon, Inc., a self-certified small disadvantaged business for-profit organization, to provide serum metabolomic profiling services in support of the COMETS Consortium's research on glioma risk. The $403,620.00 delivery order contract was awarded on September 16, 2019 with a completion date of August 31, 2021. Metabolon has extensive experience providing metabolomics analysis services to federal agencies like the Department of Veterans Affairs, Food and Drug Administration, and Department of Defense to support biomedical research and regulatory science initiatives. This contract appears to be part of the National Cancer Institute's broader Metabolomic Profiling for Molecular Epidemiology Studies program, leveraging Metabolon's metabolomics capabilities to advance research on glioma, a type of brain cancer.
Quick answers
Who was awarded contract 75N91019F00131?
75N91019F00131 was awarded to Metabolon, Inc. by National Cancer Institute (National Institutes of Health) on September 16, 2019.
How much is contract 75N91019F00131 worth?
The government has obligated $403,620 on 75N91019F00131.
Is contract 75N91019F00131 an order under another contract?
Yes. 75N91019F00131 is a delivery order under HHSN261201700009I, an indefinite delivery contract.
Was contract 75N91019F00131 competed?
The extent of competition for 75N91019F00131 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award